[News] Kenya sounds alarm over counterfeit cancer drugs

June, 06, 2024 | Select Oncology Journal Articles

A recent discovery of counterfeit Herceptin (trastuzumab) in circulation has prompted Kenya’s drugs regulatory authority, the Pharmacy and Poisons Board (PPB; Nairobi, Kenya), to warn citizens and residents to be on alert for batches of the counterfeit drug. In a statement, the PPB urged Kenyans to avoid and report the batch of fake Herceptin (440 mg) that it said is being distributed illegally in the East African country.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy